PT Kimia Farma Tbk (IDX:KAEF)
334.00
-14.00 (-4.02%)
Nov 20, 2026, 4:00 PM WIB
PT Kimia Farma Tbk Revenue
PT Kimia Farma Tbk had revenue of 2.37T IDR in the quarter ending September 30, 2026, a decrease of -10.04%. This brings the company's total for the last twelve months to 9.29T, up 2.29% year-over-year. In the year 2025, PT Kimia Farma Tbk had annual revenue of 9.22T, down -7.20%. That makes PT Kimia Farma Tbk the 11,182nd largest company in the world by revenue and 131st in Indonesia.
Revenue (ttm)
9.29T
Revenue Growth
+2.29%
P/S Ratio
0.20
Revenue / Employee
1.01B
Employees
9,218
Market Cap
1.86T
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full PT Kimia Farma Tbk breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.22T | -715.63B | -7.20% |
| Dec 31, 2024 | 9.94T | 67.12B | 0.68% |
| Dec 31, 2023 | 9.87T | 639.17B | 6.92% |
| Dec 31, 2022 | 9.23T | -3.62T | -28.19% |
| Dec 31, 2021 | 12.86T | 2.85T | 28.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Enseval Putera Megatrading Tbk. | 35.63T |
| PT Medela Potentia Tbk | 16.28T |
| PT Soho Global Health Tbk | 11.13T |
| PT Millennium Pharmacon International Tbk | 4.39T |
| PT Itama Ranoraya Tbk | 1.04T |
| PT Diastika Biotekindo Tbk | 224.95B |
| PT Esa Medika Mandiri Tbk | 223.91B |